Yes, they will generate income from it. Yes, it will be included in their revenue. I am not disputing that, that is how a business works.
But you are basing your comment of "disappointing revenue" on a contract that has been signed before the product is commercial. ie, before the product is available to market to actually generate its full revenue. M
If this announcement was the end of quarter financials after commercialisation and the only revenue generated was that of this agreement, then yes; we would ALL be seriously disappointed with the revenue.
But it's not, it's just an agreement to use the product as a first line of care in an organisation with around 5000 patients per annum. A tiny/minute sector of the target market.
EPT Price at posting:
6.5¢ Sentiment: Buy Disclosure: Held
